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CASE REPORT
First Experience of Inserting a Metallic Mesh Stent (Uventa Stent) in Malignant Ureteral Obstruction in 
Iran
Mohammad Ali Ghaed,1*, Maziar Daniali,2 Mohammad Ebrahimian3
Malignant ureteral obstruction is usually caused by an extrinsic compression including intra-abdominal cancers. 
One of the treatment modalities decompressing the obstruction is applying stent to open the ureter. Metallic Stent 
is an effective instrument which we used for the first time in Iran in our patient who had a metastatic colon cancer 
with a single kidney and we used a Novel, Double-Layered, Coated, Self-expandable Metallic Mesh Stent (Uventa 
Stent) to keep the ureter open. After six months of follow up with ureteroscopy, there was no obstruction any more.
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INTRODUCTION
A variety of pelvic, retroperitoneal or metastatic malignancies may cause ureteral obstruction. Ureteral ob-struction secondary to malignancy presents a challenging management scenario for the urologist. Traditional 
treatment modalities such as polymeric ureteral stents and percutaneous nephrostomy (PCN) tubes, an unwilling 
procedure because of daily life limitations, may be impaired by the progression of tumor.(1,2)
We report a 68-year-old man with metastatic colon cancer and right single kidney that we found his malignant 
ureteral obstruction due to colon cancer by ureteroscopic evaluation. This report was approved by the Ethics Com-
mittee of Iran University of Medical Sciences. An informed consent was taken from the patient.
CASE REPORT
A 68-year-old man with metastatic colon cancer referred to our clinic because of hydro-uretero-nephrosis and 
raised creatinine last year. He had a flank pain but no tenderness without any other symptoms. He had a past surgi-
cal history of left nephrectomy 10 years ago because of left kidney cancer and also a total colectomy+ileosigmoid 
anastomosis three years ago. His serum creatinine was 2.2 mg/dL. Pre-operation imaging including ultrasonogra-
phy and computed tomography (CT) scan made us suspicious to internal stricture of the ureter. Proving the 
Figure 1. Fluoroscopic view of the stricture during surgery. Figure 2. Ureteroscopic view of the stricture during surgery.
existence of stricture and accessing the exact length of 
it, we performed uretersocopy. On ureteroscopy, he had 
a stricture in the middle of ureter.
We inserted a temporary Double J (DJ) stent which did 
not help to solve the obstruction and creatinine rised. 
After that we used the Uventa stent, a double-layered, 
coated, self-expandable metallic mesh stent in the mid-
dle of the right ureter to open the stricture. (Figures 1, 
2) After placing the stent, patient’s creatinine decreased. 
We requested an intravenous pyelogram (IVP) after 
the surgery which seemed to be good. (Figure 3) Six 
months later, we re-evaluated the patient by ureteros-
copy. There was no stricture anymore and the stent was 
in the correct position. Patient had no more complain of 
flank pain. Serum creatinine was in the normal range. 
Then we requested an IVP for the patient. (Figure 4)
DISCUSSION
Using a metal stent is not a common way to open the 
obstruction of ureter secondary to malignancy.(3) Uventa 
stent, a type of metal stent, is a nickel-titanium alloy, 
segmental, thermally expandable stent.(4) Being ther-
mo- and self-expandable and providing less frequent 
complications including irritation are considered to be 
the advantages of Uventa stent.(4,5) Chung et al. believed 
that using Uventa metal stent is an effective option to 
decrease malignant obstruction of ureter’s symptoms.(4)
As we reviewed in literatures, Uventa stent for ureteral 
stricture was manufactured since 2013 and a few coun-
tries like Italy, Spain and North Korea used this stent 
recently. The total number of the patients in whom the 
Uventa ureteral stents were inserted is less than a hun-
dred.(6)
Although long term follow up of these patients are not 
available, but short and middle term follow up show the 
efficacy and safety of these stents. After stent insertion, 
the patient should be under close follow up with IVP or 
ureteroscopy due to delayed stricture. The stent should 
Figure 3. Intravenous pyelography after the surgery. Figure 4. Intravenous pyelography 6 months after the procedure.
be removed 12 months later.(7) No severe complications 
are mentioned but some minor complications like per-
sistent flank pain, lower urinary tract infection and stent 
migration are considered in previous studies.(8) Our 
patient had no minor and major complications and six 
month ureteroscopic follow up demonstrated the paten-
cy of the metallic stent. Re-evaluating the patient using 
ureteroscopy had some reasons including confirming 
the patency of the stent and excluding stent encrusta-
tion. As stent failure is a result of tumor progression in 
other parts of the ureteral segment, long term follow up 
of our patient is obligatory.
In conclusion, there are different treatment strategies 
for the management of malignant ureteral obstruction. 
Due to complications and patient’s complains, inserting 
a ureteral metal stent (such as Uventa stent) seems to be 
a safe and efficient treatment for these patients.
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